Skip to main content

ACRV

Acrivon Therapeutics, Inc.

Company with tickers: ACRV

CIK
1781174
CUSIP
004890109
Shares Outstanding
42,801,729
13F Activity (30d)
34 filings 32 filers

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 44
Total Value: $22,568,194
Total Shares: 16,236,130

Institutional Ownership Trend

16 quarters

Holder Concentration

Across 44 13F filers · Δ vs Dec 31, 2025
Top Holder
51.4%
Dec 2023 → Mar 2026 · range 22.6% – 56.3%
+6.6 pts
Top 5
79.8%
Dec 2023 → Mar 2026 · range 73.6% – 88.8%
+6.2 pts
Top 10
93.0%
Dec 2023 → Mar 2026 · range 88.1% – 96.5%
+4.9 pts
HHI
2,935
Dec 2023 → Mar 2026 · range 1,391 – 3,569
Highly concentrated+625

Quarterly Activity

vs Dec 31, 2025
New
10
Increased
11
Decreased
11
Sold Out
14
Unchanged
12
Holder count: -4
Institutional value: -49.7%
Shares held: -12.8%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 44 of 44
Export CSV
Holder Value (USD) % of 13F Shares Open